Company intelligence / Profile preview

Olive Diagnostics

Jerusalem, Israel

Ownership: Private
Development stage: Other

Overview

Olive Diagnostics has developed a toilet-mounted, 100% passive, non-invasive real-time urinalysis device (Olive KG) that continuously analyzes urine using optics, IoT, and AI to support early disease detection and chronic disease management in home and remote patient monitoring settings.[1][2] It is at the final stages of R&D with product launch expected around end of 2024 and early commercialization in home-based diagnostics and RPM use cases.[1]

Therapeutic areas: NephrologyOtherMetabolic Disorders
Modalities: DeviceNon-pharmacological therapy
Industry: Physiological Monitoring

Partnerships

Maccabi Healthcare ServicesAmgen VenturesMekorotPlug and Play JapanGoogle for Startups Growth Academy: AI for CybersecurityeHealth Ventures

Beyond the preview

Go deeper on Olive Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Olive Diagnostics.

Explore the full profile